Drug:
Reaction: NASOPHARYNGITIS
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555308 |
US |
2 | |
Nasopharyngitis, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 2 | 26555312 |
US |
2 | |
Myocardial infarction, Diabetes mellitus, Blood glucose increased, Nasopharyngitis, Throat irritation, Cough, Headache, Visual impairment, |
||||
INCLISIRAN, |
||||
| 3 | 26555769 |
US |
2 | |
Multiple sclerosis, Bronchitis, Nasopharyngitis, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 4 | 26556461 |
EU |
1 | 2 |
Jaundice, Muscle tightness, Metabolic disorder, Sleep disorder, Vaccination site induration, Dermatitis atopic, Infection, Upper respiratory tract infection, Vaccination site oedema, Mucous stools, Feeding disorder, Faeces discoloured, Crying, Urticaria, Abdominal pain, Oral candidiasis, Vaccination site erythema, Diarrhoea, Decreased appetite, Irritability, Weight gain poor, Altered state of consciousness, Diarrhoea haemorrhagic, Immune system disorder, Syncope, Poor feeding infant, Abdominal pain upper, Lethargy, Seizure, Dermatitis allergic, Nasopharyngitis, Somnolence, Erythema, Rash, Vaccination site pain, Nervousness, Vomiting, |
||||
| 5 | 26556507 |
EU |
88 | 2 |
Cardiac failure acute, Gastric cancer, Fluid intake reduced, Condition aggravated, Tachycardia, Muscular weakness, Nasopharyngitis, Obsessive-compulsive disorder, Mobility decreased, Vitamin B12 decreased, Chronic gastritis, Fatigue, |
||||
DICLOFENAC EPOLAMINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 6 | 26556634 |
CN |
1 | |
Death, Nausea, Pallor, Tremor, Disease recurrence, Decreased appetite, Fatigue, Nasopharyngitis, Metastases to liver, Pulmonary mass, Neoplasm progression, General physical health deterioration, Gait disturbance, Somnolence, Confusional state, |
||||
TRASTUZUMAB, TRASTUZUMAB, OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, |
||||
| 7 | 26556638 |
EU |
88 | 2 |
Gastric cancer, Cardiac failure acute, Obsessive-compulsive disorder, Fluid intake reduced, Vitamin B12 decreased, Condition aggravated, Muscular weakness, Mobility decreased, Nasopharyngitis, Tachycardia, Fatigue, Chronic gastritis, |
||||
DICLOFENAC, DICLOFENAC SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 8 | 26556708 |
US |
2 | |
Nasopharyngitis, Sinus disorder, |
||||
TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, WARFARIN SODIUM, WARFARIN, LEVONORGESTREL, ALLOPURINOL, POTASSIUM CHLORIDE, SILDENAFIL CITRATE, OXYGEN, 0XYGEN, IRON, SPIRONOLACTONE, |
||||
| 9 | 26556731 |
CA |
2 | |
Feeling abnormal, Gait inability, Movement disorder, Drug hypersensitivity, Injection site pain, Erythema, Myalgia, Insomnia, Cough, Gait disturbance, Nasopharyngitis, Pruritus, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, |
||||
| 10 | 26556946 |
US |
70 | 2 |
Nasopharyngitis, Nasal congestion, Nasal obstruction, Rhinorrhoea, Anosmia, |
||||
DUPILUMAB, |
||||
| 11 | 26556947 |
US |
41 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 12 | 26556953 |
US |
57 | 1 |
Productive cough, Nasopharyngitis, Rhinorrhoea, |
||||
DUPILUMAB, |
||||
| 13 | 26557351 |
66 | ||
Muscle contracture, Hypokinesia, Nasopharyngitis, Oropharyngeal pain, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 14 | 26557857 |
US |
23 | |
Nasopharyngitis, |
||||
BUROSUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, MELOXICAM, |
||||
| 15 | 26557901 |
US |
71 | 2 |
Nasopharyngitis, Bronchitis, Device malfunction, Inappropriate schedule of product administration, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 16 | 26558037 |
US |
77 | 1 |
Nasopharyngitis, Cough, Oropharyngeal pain, Sneezing, Drug ineffective, |
||||
DUPILUMAB, LOSARTAN POTASSIUM, LOSARTAN, MONTELUKAST SODIUM, MONTELUKAST, PRAVASTATIN SODIUM, UPADACITINIB, |
||||
| 17 | 26558103 |
US |
79 | 2 |
Sinus disorder, Nasopharyngitis, Hypersensitivity, Dyspnoea, |
||||
TADALAFIL, AMBRISENTAN, TREPROSTINIL, |
||||
| 18 | 26558752 |
EU |
71 | 2 |
Cytokine release syndrome, Pleural effusion, Nephropathy, Neutropenia, Arthralgia, Bone pain, Pyrexia, Diarrhoea, Nasopharyngitis, Cough, |
||||
| 19 | 26559001 |
CA |
33 | |
Condition aggravated, Malaise, Mouth swelling, Oral pain, Chills, Dizziness, Fatigue, Nasopharyngitis, Nausea, Pyrexia, Tooth abscess, Tooth infection, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, LORAZEPAM, MESALAMINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PREDNISONE, PREDNISONE, MESALAMINE, |
||||
| 20 | 26559071 |
EU |
27 | 2 |
Lower respiratory tract infection, Nasopharyngitis, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
| 21 | 26559077 |
US |
71 | |
Pneumonia, Asthma, Nasopharyngitis, Dermatitis atopic, |
||||
| 22 | 26559080 |
US |
46 | 2 |
Cough, Nasopharyngitis, |
||||
TRALOKINUMAB-LDRM, |
||||
| 23 | 26559133 |
|||
Meniscus injury, Knee operation, Adverse drug reaction, Pyrexia, Nasopharyngitis, Intentional dose omission, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 24 | 26559154 |
US |
71 | 1 |
Nasopharyngitis, |
||||
POMALIDOMIDE, |
||||
| 25 | 26559230 |
CA |
45 | 2 |
Abdominal discomfort, Arthralgia, Autoimmune disorder, Blood cholesterol increased, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Drug ineffective, Eye injury, Folliculitis, Gait inability, Gastrointestinal disorder, Headache, Helicobacter infection, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect route of product administration, Infection, Irritable bowel syndrome, Liver disorder, Lower respiratory tract infection, Lupus vulgaris, Maternal exposure during pregnancy, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Pemphigus, Peripheral swelling, Off label use, Pruritus, Rash, Rheumatic fever, Rheumatoid factor positive, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Vomiting, Wheezing, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, |
||||
| 26 | 26560145 |
75 | ||
Nasopharyngitis, Off label use, |
||||
| 27 | 26560228 |
US |
36 | 2 |
Influenza, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 28 | 26560309 |
65 | ||
Ankylosing spondylitis, Rhinorrhoea, Asthma, Cough, Nasopharyngitis, Back disorder, Gait disturbance, |
||||
CERTOLIZUMAB PEGOL, ALBUTEROL SULFATE, FOLIC ACID, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 29 | 26560411 |
US |
45 | 1 |
Nasopharyngitis, Nasal congestion, Condition aggravated, Rhinorrhoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 30 | 26560640 |
US |
61 | 1 |
Thrombosis, Dehydration, Tremor, Nasopharyngitis, Peripheral swelling, Contraindicated product administered, |
||||
| 31 | 26561281 |
US |
2 | |
Nasopharyngitis, Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 32 | 26561502 |
US |
72 | |
Arthralgia, Joint stiffness, Limb discomfort, Nasopharyngitis, Head discomfort, Cough, Injection site pain, Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 33 | 26561520 |
CA |
64 | 2 |
Ileostomy, Colitis, Nasopharyngitis, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 34 | 26561535 |
JP |
58 | 1 |
Lacunar infarction, Diarrhoea, Diarrhoea, Nasopharyngitis, Diarrhoea, Blood parathyroid hormone decreased, |
||||
DARBEPOETIN ALFA, TENAPANOR HYDROCHLORIDE, TENAPANOR HYDROCHLORIDE, TENAPANOR HYDROCHLORIDE, TENAPANOR HYDROCHLORIDE, LANTHANUM CARBONATE, AZILSARTAN KAMEDOXOMIL, FUROSEMIDE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, PRAVASTATIN SODIUM, EMPAGLIFLOZIN, CARVEDILOL, AMLODIPINE BESYLATE, PRASUGREL HYDROCHLORIDE, |
||||
| 35 | 26561546 |
US |
65 | 2 |
Nasopharyngitis, |
||||
AVAPRITINIB, ONDANSETRON HYDROCHLORIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, FLUTICASONE PROPIONATE, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 36 | 26561570 |
US |
||
Nasopharyngitis, |
||||
EVOLOCUMAB, |
||||
| 37 | 26550215 |
US |
72 | 1 |
Nasopharyngitis, Cough, |
||||
MEPOLIZUMAB, |
||||
| 38 | 26550234 |
US |
2 | |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 39 | 26550289 |
78 | ||
Nasopharyngitis, Psoriasis, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 40 | 26550372 |
US |
2 | |
Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, |
||||
PRAVASTATIN SODIUM, DUPILUMAB, |
||||
| 41 | 26550439 |
CA |
70 | 2 |
Neuromyelitis optica spectrum disorder, Fatigue, Headache, Nasopharyngitis, Feeling abnormal, Hypertension, Sinusitis, Butterfly rash, Asthenia, |
||||
INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, RITUXIMAB, |
||||
| 42 | 26550511 |
US |
4 | 1 |
Nasopharyngitis, Sexual dysfunction, |
||||
VORTIOXETINE, VORTIOXETINE, VORTIOXETINE, LISDEXAMFETAMINE DIMESYLATE, TADALAFIL, |
||||
| 43 | 26550562 |
US |
55 | 2 |
Fatigue, Arthralgia, Abdominal discomfort, Nasopharyngitis, |
||||
DOSTARLIMAB, |
||||
| 44 | 26550577 |
US |
72 | 1 |
Nasopharyngitis, |
||||
RELUGOLIX, RELUGOLIX, IRON, FOLIC ACID, ERGOCALCIFEROL, FAMOTIDINE, BUPROPION HYDROCHLORIDE, ALLOPURINOL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LOPERAMIDE HYDROCHLORIDE, MAGNESIUM, |
||||
| 45 | 26550620 |
US |
52 | 1 |
Nasopharyngitis, |
||||
LENALIDOMIDE, |
||||
| 46 | 26550675 |
US |
2 | |
Hypertrophic cardiomyopathy, Injection site papule, Injection site pruritus, Nasopharyngitis, Bronchitis, Condition aggravated, Pharyngitis, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 47 | 26550683 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, C-reactive protein, C-reactive protein abnormal, Chest pain, Decreased appetite, Deep vein thrombosis postoperative, Drug hypersensitivity, Fatigue, Gait inability, Hypersensitivity, Hypertension, Hypertransaminasaemia, Hypoaesthesia, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Leukopenia, Live birth, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lupus vulgaris, Malaise, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Osteoarthritis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pregnancy, Pruritus, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid factor positive, Sciatica, Sinusitis, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Ulcer haemorrhage, Maternal exposure during pregnancy, Prescribed overdose, Product use in unapproved indication, Off label use, Product use issue, Therapy non-responder, Treatment failure, Therapeutic product effect decreased, Drug ineffective, Therapeutic response decreased, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, CERTOLIZUMAB PEGOL, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, MAGNESIUM, MAGNESIUM, ERGOCALCIFEROL, RAMIPRIL, SULFASALAZINE, PIROXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LORAZEPAM, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LANSOPRAZOLE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, CYANOCOBALAMIN, FISH OIL, CAFFEINE, LORAZEPAM, |
||||
| 48 | 26550777 |
67 | ||
Nasopharyngitis, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 49 | 26550837 |
US |
69 | 2 |
Nasopharyngitis, Respiratory tract infection, Malaise, |
||||
LENALIDOMIDE, |
||||
| 50 | 26550943 |
US |
67 | |
Cough, Nasopharyngitis, |
||||
TIRZEPATIDE, |
||||
| 51 | 26551003 |
CO |
87 | 2 |
Cerebral ischaemia, Nasopharyngitis, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 52 | 26551485 |
US |
46 | |
Nasopharyngitis, |
||||
TIRZEPATIDE, |
||||
| 53 | 26551580 |
EU |
88 | 2 |
Cardiac failure acute, Gastric cancer, Muscular weakness, Mobility decreased, Condition aggravated, Tachycardia, Fatigue, Nasopharyngitis, Vitamin B12 decreased, Chronic gastritis, Fluid intake reduced, Obsessive-compulsive disorder, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC, DICLOFENAC SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TECHNETIUM TC-99M, |
||||
| 54 | 26551647 |
US |
26 | 2 |
Nasopharyngitis, |
||||
NATALIZUMAB, |
||||
| 55 | 26551733 |
CA |
65 | 2 |
Abdominal pain, Aortic aneurysm, Arterial occlusive disease, Back pain, Brain operation, Burning sensation, Cerebrovascular accident, Contusion, Diabetes mellitus, Diarrhoea, Drug ineffective, Gait disturbance, Infection, Nasopharyngitis, Pain in extremity, Parathyroid disorder, Peripheral artery occlusion, Peripheral swelling, Pneumonia, Product complaint, Product dose omission issue, Raynaud^s phenomenon, Respiratory syncytial virus infection, Neuralgia, Rosacea, Stress, Systemic lupus erythematosus, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BELIMUMAB, BELIMUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 56 | 26551982 |
US |
35 | 2 |
Nasopharyngitis, Aphonia, |
||||
SATRALIZUMAB, |
||||
| 57 | 26552690 |
38 | 1 | |
Lethargy, Dizziness, Anaemia, Feeling abnormal, Fatigue, Influenza, Nasopharyngitis, Hidradenitis, Infectious mononucleosis, Inappropriate schedule of product administration, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB-RYVK, |
||||
| 58 | 26552939 |
US |
2 | |
Fall, Prescribed underdose, Nasopharyngitis, |
||||
OMAVELOXOLONE, |
||||
| 59 | 26553122 |
EU |
88 | 2 |
Cardiac failure acute, Gastric cancer, Fluid intake reduced, Condition aggravated, Tachycardia, Muscular weakness, Fatigue, Nasopharyngitis, Obsessive-compulsive disorder, Mobility decreased, Vitamin B12 decreased, Chronic gastritis, |
||||
DICLOFENAC, DICLOFENAC SODIUM, AMLODIPINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 60 | 26553294 |
US |
61 | 2 |
Nephrolithiasis, Nasopharyngitis, Psoriasis, Therapeutic product effect incomplete, Arthralgia, Musculoskeletal stiffness, |
||||
RISANKIZUMAB-RZAA, |
||||
| 61 | 26553631 |
US |
1 | |
Myalgia, Nasopharyngitis, |
||||
TOCILIZUMAB, AMBRISENTAN, SELEXIPAG, |
||||
| 62 | 26553723 |
EU |
51 | 2 |
Drug-induced liver injury, Hepatic enzyme increased, Leukopenia, Cholestasis, Nasopharyngitis, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, GOSERELIN, |
||||
| 63 | 26554050 |
US |
78 | 2 |
Injection site pain, Nasopharyngitis, Depressed mood, Depression, Back pain, |
||||
ENSIFENTRINE, DUPILUMAB, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BIOTIN, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, LOVASTATIN, TIOTROPIUM BROMIDE, VITAMIN C, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 64 | 26554861 |
US |
42 | 2 |
Nasal congestion, Chest discomfort, Nasopharyngitis, |
||||
SPARSENTAN, PREDNISONE, BUPROPION HYDROCHLORIDE, INSULIN GLARGINE, DAPAGLIFLOZIN, GLIPIZIDE, GLIPIZIDE-TABLETS, FAMOTIDINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 65 | 26554867 |
CA |
24 | 2 |
Throat irritation, Illness, Malaise, Nasopharyngitis, Inappropriate schedule of product administration, Off label use, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 66 | 26555230 |
US |
56 | 2 |
Off label use, Nasopharyngitis, Sinus disorder, |
||||
AVAPRITINIB, |
||||
| 67 | 26555247 |
EU |
88 | 2 |
Cardiac failure acute, Fatigue, Chronic gastritis, Condition aggravated, Fluid intake reduced, Tachycardia, Gastric cancer, Mobility decreased, Muscular weakness, Obsessive-compulsive disorder, Vitamin B12 decreased, Nasopharyngitis, |
||||
DICLOFENAC, DICLOFENAC SODIUM, AMLODIPINE BESYLATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 68 | 26549024 |
CA |
38 | |
Asthma, Blood pressure increased, Blood urea decreased, Body mass index increased, Body temperature decreased, Dyspnoea, Forced expiratory volume decreased, Glomerular filtration rate decreased, Malaise, Middle insomnia, Obesity, Obstructive airways disorder, Oropharyngeal pain, Pain, Pneumonia, Psoriatic arthropathy, Reversible airways obstruction, Sensitivity to weather change, Swelling, Swelling face, Total lung capacity decreased, Weight decreased, Pyrexia, Urticaria, Sinusitis, Pruritus, Arthralgia, Cardiac failure congestive, Diarrhoea, Nasopharyngitis, Influenza, Cough, Anaphylactic reaction, Drug hypersensitivity, Weight increased, Respiratory disorder, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, SECUKINUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CICLESONIDE, RABEPRAZOLE, RANITIDINE, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
| 69 | 26549301 |
US |
12 | 1 |
Nasopharyngitis, Rhinorrhoea, Cough, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 70 | 26549346 |
US |
15 | 2 |
Sinus polyp, Nasopharyngitis, Sinusitis, |
||||
DUPILUMAB, |
||||
| 71 | 26549442 |
US |
20 | 1 |
Nasopharyngitis, Asthma, Dyspnoea, Incorrect dose administered, |
||||
DUPILUMAB, BENRALIZUMAB, |
||||
| 72 | 26549504 |
US |
93 | 1 |
Nasopharyngitis, Productive cough, Dry eye, Myalgia, Orthostatic hypotension, Blood pressure decreased, Chest discomfort, Cough, Productive cough, Dyspnoea, Dyspnoea exertional, |
||||
DUPILUMAB, |
||||
| 73 | 26549731 |
US |
58 | 2 |
Nasopharyngitis, Cough, Nasal congestion, Wheezing, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 74 | 26549835 |
US |
70 | 2 |
Nephrolithiasis, Rhinorrhoea, Respiratory tract congestion, Nasopharyngitis, Nausea, Blood potassium increased, Constipation, Dry mouth, Rash, Lymphocyte count abnormal, Spleen disorder, Abdominal pain upper, |
||||
ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, |
||||
| 75 | 26546754 |
US |
54 | 1 |
Sinusitis, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 76 | 26546833 |
US |
2 | |
Nasopharyngitis, |
||||
SARILUMAB, FUROSEMIDE, LOVASTATIN, AZELAIC ACID, PREDNISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, OXYMETAZOLINE HYDROCHLORIDE, OXYMETAZOLINE HYDROCHLORIDE., POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LORATADINE, LORATADINE TABLET, |
||||
| 77 | 26546916 |
US |
61 | 1 |
Nasopharyngitis, Pharyngeal swelling, Condition aggravated, Injection site pain, |
||||
DUPILUMAB, |
||||
| 78 | 26547464 |
US |
2 | |
Nasopharyngitis, |
||||
AVALGLUCOSIDASE ALFA-NGPT, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FAMOTIDINE, BACLOFEN, LACOSAMIDE, |
||||
| 79 | 26547478 |
JP |
86 | 2 |
Physical deconditioning, Nasopharyngitis, Aphonia, Cognitive disorder, Fall, Skin abrasion, Insomnia, Chronic obstructive pulmonary disease, Inappropriate schedule of product administration, Off label use, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, BISOPROLOL FUMARATE, PITAVASTATIN CALCIUM, PITAVASTATIN, RIVAROXABAN, |
||||
| 80 | 26547559 |
US |
65 | 2 |
Nasopharyngitis, |
||||
DUPILUMAB, ALBUTEROL SULFATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, OLMESARTAN MEDOXOMIL, PANTOPRAZOLE, ROSUVASTATIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, HYDROCHLOROTHIAZIDE, |
||||
| 81 | 26547590 |
US |
32 | 2 |
Nasopharyngitis, Illness, Cough, Nasal congestion, Chills, |
||||
DUPILUMAB, ALBUTEROL SULFATE, LORATADINE, LORATADINE TABLET, RISANKIZUMAB-RZAA, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 82 | 26547658 |
US |
62 | 2 |
Nasopharyngitis, Inappropriate schedule of product administration, |
||||
SARILUMAB, SARILUMAB, |
||||
| 83 | 26547794 |
23 | ||
Skin cancer, Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 84 | 26548005 |
US |
32 | 2 |
Upper respiratory tract infection, Nasopharyngitis, Rhinorrhoea, Upper-airway cough syndrome, Throat irritation, |
||||
DUPILUMAB, |
||||
| 85 | 26548080 |
US |
||
Chest discomfort, Menopausal symptoms, Drug ineffective, Nasopharyngitis, Depressed mood, Fatigue, Insomnia, Hot flush, Product substitution issue, Product quality issue, |
||||
ESTRADIOL, ESTRADIOL, ESTRADIOL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 86 | 26548225 |
CA |
2 | |
Visual impairment, Dizziness, Ear congestion, Influenza, Nasopharyngitis, Vertigo, Asthenia, |
||||
ADALIMUMAB-RYVK, |
||||
| 87 | 26548339 |
US |
63 | 2 |
Nasopharyngitis, Nasal congestion, Rhinorrhoea, Chronic obstructive pulmonary disease, Dyspnoea, Asthenia, Product preparation error, |
||||
DUPILUMAB, |
||||
| 88 | 26548366 |
US |
2 | |
Malaise, Seasonal allergy, Nasopharyngitis, Fatigue, |
||||
ELIGLUSTAT, MAGNESIUM, IMIGLUCERASE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EPINEPHRINE, CEPHALEXIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 89 | 26548410 |
US |
60 | 2 |
Nasal congestion, Productive cough, Cough, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 90 | 26548710 |
US |
54 | 2 |
Nasopharyngitis, Condition aggravated, Rhinorrhoea, Respiratory tract congestion, Injection site urticaria, Injection site erythema, Injection site swelling, Injection site warmth, Product use in unapproved indication, |
||||
DUPILUMAB, CALCIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, RALOXIFENE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, LINACLOTIDE, MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FAMOTIDINE, METOCLOPRAMIDE HYDROCHLORIDE, SPIRONOLACTONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 91 | 26548729 |
US |
27 | 2 |
Nasopharyngitis, Respiratory tract congestion, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 92 | 26548747 |
US |
2 | |
Illness, Cough, Nasopharyngitis, Intentional product misuse, |
||||
ELIGLUSTAT, |
||||
| 93 | 26548780 |
US |
64 | 2 |
Cough, Sneezing, Nasopharyngitis, |
||||
INSULIN GLARGINE, |
||||
| 94 | 26548790 |
US |
81 | 1 |
Infection, Nasopharyngitis, Cough, Drug ineffective, |
||||
DUPILUMAB, AMLODIPINE, |
||||
| 95 | 26542027 |
US |
2 | |
Fatigue, Stomatitis, Nasopharyngitis, Dysphonia, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ONDANSETRON HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, DROSPIRENONE AND ETHINYL ESTRADIOL, AMLODIPINE BESYLATE, FLUTICASONE PROPIONATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, PEMBROLIZUMAB, LOSARTAN POTASSIUM, LOSARTAN, CETIRIZINE HYDROCHLORIDE, LENVATINIB, |
||||
| 96 | 26542281 |
US |
2 | |
Nasopharyngitis, |
||||
| 97 | 26542314 |
US |
61 | |
Condition aggravated, Nasopharyngitis, |
||||
TOCILIZUMAB, |
||||
| 98 | 26542428 |
US |
64 | 1 |
Nausea, Flatulence, Malaise, Illness, Peripheral swelling, Nasopharyngitis, Pyrexia, Rhinorrhoea, Oral herpes, Aphthous ulcer, Swelling face, |
||||
BEMPEDOIC ACID, EVOLOCUMAB, FINASTERIDE, |
||||
| 99 | 26542493 |
US |
2 | |
Influenza, Nasopharyngitis, Decreased appetite, Weight decreased, Cough, Illness, Bronchitis, |
||||
BEMPEDOIC ACID, CITALOPRAM, CITALOPRAM HYDROBROMIDE, OMEPRAZOLE MAGNESIUM, |
||||
| 100 | 26542591 |
CA |
2 | |
Meningitis, Nasopharyngitis, Pyrexia, |
||||
UPADACITINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
